{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:58:46Z","timestamp":1779893926317,"version":"3.53.1"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032063","name":"RANZCOG Women\u2019s Health Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100032063","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council of Australia","award":["1176922"],"award-info":[{"award-number":["1176922"]}]},{"name":"National Health and Medical Research Council of Australia","award":["2017897"],"award-info":[{"award-number":["2017897"]}]},{"name":"National Health and Medical Research Council of Australia","award":["2026158"],"award-info":[{"award-number":["2026158"]}]},{"DOI":"10.13039\/501100017018","name":"Wallenberg Centre for Molecular and Translational Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017018","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mercy Health Foundation"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Magnesium sulphate halves the risk of eclampsia. There is no consensus on who to give magnesium sulphate prophylaxis because clinical tools are poor at identifying those at risk. Known prodromal symptoms such as headache, visual disturbance, or epigastric pain have modest associations with eclampsia. We set out to identify new prodromal symptoms of eclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>This case-control study prospectively recruited participants in South Africa and Pakistan who had eclampsia, preeclampsia, or normotensive pregnancies. We asked whether they experienced 20 neurological symptoms, within 7 days of the seizure for those who had eclampsia. The primary analysis was the likelihood of symptoms occurring before eclampsia, compared to being present with preeclampsia.<\/jats:p>\n                    <jats:p>\n                      341 participants were recruited with eclampsia, 1,355 with preeclampsia and 389 with normotensive pregnancies. When comparing symptoms among those who had eclampsia versus preeclampsia, the odds ratios (OR) were 2.56 (95% confidence interval (CI) [1.81,3.62];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for headache, 5.73 (95% CI [4.44,7.39];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for visual disturbances and 2.25 (95% CI [1.76,2.89];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for epigastric pain. We identified 10 symptoms with odds ratios over 10 for eclampsia. Odds ratios were 42.03 (95% CI [23.66,74.68];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for twitching\/jerking limbs (30.5% eclampsia versus 1% preeclampsia); 36.00 (95% CI [18.34,70.65];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for affected hearing (21.1% versus 0.7%)\u2019 33.60 (95% CI [21.39,52.78];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for affected mind state (38.7% versus 1.8%); 33.12 (95% CI [19.46, 54.37];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for impaired speech; 23.71 (95% CI [16.49,34.10];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for feelings of doom; 26.59 (95% CI [7.82,90.41];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for severe vertigo; 20.52 (95% CI [14.22,29.63];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for confusion; 18.16 (95% CI [10.76,30.66];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for jitters; 15.18 (95% CI [11.34,20.33];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for difficulty concentrating; and 10.49 (95% CI [6.76,16.27];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for weakness\/paralysis. These symptoms were rare among normotensive pregnancies. Only 2.4% of women with eclampsia did not experience any prodromal symptoms. This study is limited by the fact that we asked about prodromal symptoms after the seizure happened, and the potential for recall bias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ten prodromal symptoms exhibit far stronger associations with eclampsia than headache, visual disturbances, or epigastric pain. Eclampsia is uncommon without any prodromal symptoms. It may be useful to screen these symptoms among women with preeclampsia as part of clinical history taking to guide management. They could help direct magnesium sulphate prophylaxis to those with a higher risk of eclampsia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004994","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:21:24Z","timestamp":1777396884000},"page":"e1004994","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identifying novel prodromal symptoms of eclampsia: A two-country, case-control study"],"prefix":"10.1371","volume":"23","author":[{"given":"Roxanne","family":"Hastie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6074-8692","authenticated-orcid":true,"given":"Farhatulain","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1608-8487","authenticated-orcid":true,"given":"Parinaz","family":"Mehdipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqui","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyle","family":"Gurrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-5188","authenticated-orcid":true,"given":"Anthea","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-7456","authenticated-orcid":true,"given":"Jessica A.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0406-8964","authenticated-orcid":true,"given":"Catherine","family":"Cluver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5202-9428","authenticated-orcid":true,"given":"Lina","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2319-0586","authenticated-orcid":true,"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"pmed.1004994.ref001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.09.037","article-title":"Eclampsia in the 21st century","volume":"226","author":"M Fishel Bartal","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"9321","key":"pmed.1004994.ref002","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"D Altman","year":"2002","journal-title":"Lancet"},{"key":"pmed.1004994.ref003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/1471-0528.12629","article-title":"Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health","volume":"121","author":"E Abalos","year":"2014","journal-title":"BJOG"},{"issue":"8","key":"pmed.1004994.ref004","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41440-018-0051-3","article-title":"Neuroimaging findings in women who develop neurologic symptoms in severe preeclampsia with or without eclampsia","volume":"41","author":"X Di","year":"2018","journal-title":"Hypertens Res"},{"issue":"1","key":"pmed.1004994.ref005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000161569","article-title":"Follow-up interviews after eclampsia","volume":"67","author":"AB Andersgaard","year":"2009","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"pmed.1004994.ref006","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/jog.12697","article-title":"Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia","volume":"41","author":"Y Berhan","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"pmed.1004994.ref007","volume-title":"Hypertension in pregnancy","author":"Pregnancy ATfoHi","year":"2013"},{"issue":"2","key":"pmed.1004994.ref008","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijgo.2012.01.028","article-title":"A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia\/eclampsia in real-world use","volume":"118","author":"SD McDonald","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"pmed.1004994.ref009","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/AOG.0000000000003476","article-title":"Predictive value of the signs and symptoms preceding eclampsia: a systematic review","volume":"134","author":"R Hastie","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"pmed.1004994.ref010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/AOG.0b013e3182324570","article-title":"Characterization of symptoms immediately preceding eclampsia","volume":"118","author":"SD Cooray","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"6966","key":"pmed.1004994.ref011","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/bmj.309.6966.1395","article-title":"Eclampsia in the United Kingdom","volume":"309","author":"KA Douglas","year":"1994","journal-title":"BMJ"},{"issue":"11","key":"pmed.1004994.ref012","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S1474-4422(15)00257-4","article-title":"The diagnosis of posterior reversible encephalopathy syndrome\u2013Authors\u2019 reply","volume":"14","author":"JE Fugate","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"pmed.1004994.ref013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"MA Brown","year":"2018","journal-title":"Hypertension"},{"issue":"4","key":"pmed.1004994.ref014","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00003081-198412000-00004","article-title":"History and epidemiology of preeclampsia-eclampsia","volume":"27","author":"LC Chesley","year":"1984","journal-title":"Clin Obstet Gynecol"},{"key":"pmed.1004994.ref015","author":"SOMANZ","year":"2023"},{"key":"pmed.1004994.ref016","author":"NICE","year":"2019"},{"key":"pmed.1004994.ref017","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"LA Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"pmed.1004994.ref018","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"pmed.1004994.ref019","unstructured":"WHO. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011."},{"issue":"2","key":"pmed.1004994.ref020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2021.03.017","article-title":"Cerebral perfusion pressure and autoregulation in eclampsia-a case control study","volume":"225","author":"L Bergman","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"pmed.1004994.ref021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2024.10.034","article-title":"Cerebral infarcts, edema, hypoperfusion, and vasospasm in preeclampsia and eclampsia","volume":"232","author":"L Bergman","year":"2025","journal-title":"Am J Obstet Gynecol"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:21:31Z","timestamp":1777396891000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004994"}},"subtitle":[],"editor":[{"given":"Andrew","family":"Shennan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004994","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}